× Copyright Disclaimer Privacy Policy Author Guidelines Current Issue Archive Publishing Ethics Join As Reviewer Advertise Submit Article Abstracting And Indexing Editorial Board Contact Editor-in-Chief Scope of the Journal About the Journal


JAPER is indexed in SCOPUS

Protective drugs against Risk of Intra-coronary Stent Restenosis


, , ,

Abstract

Background: Intracoronary stent restenosis (ISR) is a famous catastrophe, always following percutaneous coronary interventions (PCI). Many investigations were performed to avoid this complication by the addition of many cytotoxic drugs to stent platform for prevention of neo-intimal hyperplasia and smooth muscle cell proliferation, or by finding a protective drug against this problem, such as dual antiplatelet therapy. Our research was conducted to detect the protective drugs against the risk of intracoronary stent restenosis among all drugs of medical treatment for ischemic heart diseases. Results: The study reported that 54, 26, 54, and 34% of patients respectively administrated by clopidogrel, nitrates, angiotensin-converting enzyme inhibitors (ACEI) and statins developed ISR after PCI when compared to the other group of patients who did not develop ISR. So, these drugs were protective against the risk of ISR (P value<0.001). We also reported that 74, 4, and 90% of patients administrated respectively by aspirin, warfarin, beta-1 blockers (BB) developed ISR after PCI when compared to the other group of patients who did not develop ISR. So, there was no association between these drugs and risk of ISR (P value>0.05). Conclusions: This study concluded that clopidogrel, nitrates, ACEI, and statins are protective drugs against the risk of ISR complications after PCI procedures‎.


How to cite this article:
Vancouver
Abdelaziz TA, Mohammad RH, Gad MM, Ghareeb‎ MG‎. Protective drugs against Risk of Intra-coronary Stent Restenosis. J Adv Pharm Educ Res. 2020;10(2):60-3.
APA
Abdelaziz, T. A., Mohammad, R. H., Gad, M. M., & Ghareeb‎, M. G. ‎. (2020). Protective drugs against Risk of Intra-coronary Stent Restenosis. Journal of Advanced Pharmacy Education and Research, 10(2), 60-63.
Citation Formats:


Contact SPER Publications


SPER Publications and Solutions Pvt. Ltd.

HD - 236,
Near The Shri Ram Millenium School,
Sector 135,
Noida-Greater Noida Expressway,
Noida-201301 [Delhi-NCR] India